Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Bick

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Toxicology|January 18, 2026
Could cannabigerol protect against neuroinflammation? Insights from an in vitro microglial studyJúlia Maiara Dos Santos, Amanda Kolinski Machado, Djenifer Leticia Ulrich Bick, et al.
Breast Cancer Research and Treatment|July 3, 2014
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?Eva Maria Fallenberg, Clarisse Dromain, Felix Diekmann, et al.
European Radiology|November 30, 2016
Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluationEva M Fallenberg, Florian F Schmitzberger, Heba Amer, et al.
Communications Medicine|October 31, 2022
Artificial intelligence and machine learning in cancer imagingDow-Mu Koh, Nickolas Papanikolaou, Ulrich Bick, et al.
Journal of Ethnopharmacology|February 23, 2025
Could the inhibition of systemic NLRP3 inflammasome mediate central redox effects of yerba mate? An in silico and pre-clinical translational approachJúlia Maiara Dos Santos, Luciana Touguinha, Raquel Bridi, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Biology|November 27, 2025
Epicatechin-Loaded Nanocapsules: Development, Physicochemical Characterization, and NLRP3 Inflammasome-Targeting Anti-Inflammatory ActivityCarolina Bordin Davidson, Éricles Forrati Machado, Amanda Kolinski Machado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.
ACS Omega|August 25, 2025
Antiviral Effect of Piperine on Chikungunya Virus: <i>In Vitro</i> Evidence and <i>In Silico</i> Analysis of E1-E2 BindingJoão Augusto Pereira da Rocha, Renato Araújo da Costa, Elaine Cristina Medeiros da Rocha, et al.
Breast Cancer Research and Treatment|February 7, 2019
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancerUlrich Bick, Christoph Engel, Barbara Krug, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Toxicology|January 18, 2026
Could cannabigerol protect against neuroinflammation? Insights from an in vitro microglial studyJúlia Maiara Dos Santos, Amanda Kolinski Machado, Djenifer Leticia Ulrich Bick, et al.
Breast Cancer Research and Treatment|July 3, 2014
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?Eva Maria Fallenberg, Clarisse Dromain, Felix Diekmann, et al.
European Radiology|November 30, 2016
Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluationEva M Fallenberg, Florian F Schmitzberger, Heba Amer, et al.
Communications Medicine|October 31, 2022
Artificial intelligence and machine learning in cancer imagingDow-Mu Koh, Nickolas Papanikolaou, Ulrich Bick, et al.
Journal of Ethnopharmacology|February 23, 2025
Could the inhibition of systemic NLRP3 inflammasome mediate central redox effects of yerba mate? An in silico and pre-clinical translational approachJúlia Maiara Dos Santos, Luciana Touguinha, Raquel Bridi, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Biology|November 27, 2025
Epicatechin-Loaded Nanocapsules: Development, Physicochemical Characterization, and NLRP3 Inflammasome-Targeting Anti-Inflammatory ActivityCarolina Bordin Davidson, Éricles Forrati Machado, Amanda Kolinski Machado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.
ACS Omega|August 25, 2025
Antiviral Effect of Piperine on Chikungunya Virus: <i>In Vitro</i> Evidence and <i>In Silico</i> Analysis of E1-E2 BindingJoão Augusto Pereira da Rocha, Renato Araújo da Costa, Elaine Cristina Medeiros da Rocha, et al.
Breast Cancer Research and Treatment|February 7, 2019
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancerUlrich Bick, Christoph Engel, Barbara Krug, et al.
Pageof 6